BCRX
Price
$8.65
Change
+$0.13 (+1.53%)
Updated
Jul 22 closing price
Capitalization
1.81B
12 days until earnings call
EDIT
Price
$3.36
Change
+$0.21 (+6.67%)
Updated
Jul 22 closing price
Capitalization
281.28M
7 days until earnings call
Interact to see
Advertisement

BCRX vs EDIT

Header iconBCRX vs EDIT Comparison
Open Charts BCRX vs EDITBanner chart's image
BioCryst Pharmaceuticals
Price$8.65
Change+$0.13 (+1.53%)
Volume$3.89M
Capitalization1.81B
Editas Medicine
Price$3.36
Change+$0.21 (+6.67%)
Volume$2.62M
Capitalization281.28M
BCRX vs EDIT Comparison Chart in %
Loading...
BCRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EDIT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Regeneron Pharmaceuticals (NASDAQ:REGN), Incyte Corp (NASDAQ:INCY), Moderna (NASDAQ:MRNA), Exelixis (NASDAQ:EXEL), Arrowhead Pharmaceuticals (NASDAQ:ARWR), BioCryst Pharmaceuticals (NASDAQ:BCRX), Adaptive Biotechnologies Corp (NASDAQ:ADPT), Sarepta Therapeutics (NASDAQ:SRPT), Novavax (NASDAQ:NVAX), Nektar Therapeutics (NASDAQ:NKTR).

Industry description

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

Market Cap

The average market capitalization across the Biotechnology Industry is 2.45B. The market cap for tickers in the group ranges from 58 to 284.45B. NONOF holds the highest valuation in this group at 284.45B. The lowest valued company is SEELQ at 58.

High and low price notable news

The average weekly price growth across all stocks in the Biotechnology Industry was 7%. For the same Industry, the average monthly price growth was 19%, and the average quarterly price growth was 34%. CYCC experienced the highest price growth at 252%, while LIANY experienced the biggest fall at -87%.

Volume

The average weekly volume growth across all stocks in the Biotechnology Industry was 60%. For the same stocks of the Industry, the average monthly volume growth was 82% and the average quarterly volume growth was 108%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 83
Price Growth Rating: 56
SMR Rating: 92
Profit Risk Rating: 95
Seasonality Score: -2 (-100 ... +100)

Notable companies

The most notable companies in this group are BioCryst Pharmaceuticals (NASDAQ:BCRX).

Market Cap

The average market capitalization across the group is 1.05B. The market cap for tickers in the group ranges from 281.28M to 1.81B. BCRX holds the highest valuation in this group at 1.81B. The lowest valued company is EDIT at 281.28M.

High and low price notable news

The average weekly price growth across all stocks in the group was 3%. For the same group, the average monthly price growth was 9%, and the average quarterly price growth was 73%. EDIT experienced the highest price growth at 11%, while BCRX experienced the biggest fall at -5%.

Volume

The average weekly volume growth across all stocks in the group was 177%. For the same stocks of the group, the average monthly volume growth was 2,711% and the average quarterly volume growth was 53%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 39
P/E Growth Rating: 100
Price Growth Rating: 47
SMR Rating: 99
Profit Risk Rating: 88
Seasonality Score: 25 (-100 ... +100)
VS
BCRX vs. EDIT commentary
Jul 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCRX is a StrongBuy and EDIT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 23, 2025
Stock price -- (BCRX: $8.52 vs. EDIT: $3.15)
Brand notoriety: BCRX: Notable vs. EDIT: Not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCRX: 94% vs. EDIT: 223%
Market capitalization -- BCRX: $1.81B vs. EDIT: $281.28M
BCRX [@Biotechnology] is valued at $1.81B. EDIT’s [@Biotechnology] market capitalization is $281.28M. The market cap for tickers in the [@Biotechnology] industry ranges from $284.45B to $0. The average market capitalization across the [@Biotechnology] industry is $2.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCRX’s FA Score shows that 1 FA rating(s) are green whileEDIT’s FA Score has 0 green FA rating(s).

  • BCRX’s FA Score: 1 green, 4 red.
  • EDIT’s FA Score: 0 green, 5 red.
According to our system of comparison, EDIT is a better buy in the long-term than BCRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCRX’s TA Score shows that 4 TA indicator(s) are bullish while EDIT’s TA Score has 4 bullish TA indicator(s).

  • BCRX’s TA Score: 4 bullish, 5 bearish.
  • EDIT’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, EDIT is a better buy in the short-term than BCRX.

Price Growth

BCRX (@Biotechnology) experienced а -4.91% price change this week, while EDIT (@Biotechnology) price change was +10.53% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.09%. For the same industry, the average monthly price growth was +19.23%, and the average quarterly price growth was +33.77%.

Reported Earning Dates

BCRX is expected to report earnings on Oct 29, 2025.

EDIT is expected to report earnings on Nov 10, 2025.

Industries' Descriptions

@Biotechnology (+7.09% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BCRX($1.81B) has a higher market cap than EDIT($281M). EDIT YTD gains are higher at: 148.032 vs. BCRX (13.298). BCRX has higher annual earnings (EBITDA): 47.6M vs. EDIT (-244.52M). BCRX has more cash in the bank: 295M vs. EDIT (221M). EDIT has less debt than BCRX: EDIT (31.1M) vs BCRX (795M). BCRX has higher revenues than EDIT: BCRX (503M) vs EDIT (35.8M).
BCRXEDITBCRX / EDIT
Capitalization1.81B281M644%
EBITDA47.6M-244.52M-19%
Gain YTD13.298148.0329%
P/E RatioN/AN/A-
Revenue503M35.8M1,405%
Total Cash295M221M133%
Total Debt795M31.1M2,556%
FUNDAMENTALS RATINGS
BCRX vs EDIT: Fundamental Ratings
BCRX
EDIT
OUTLOOK RATING
1..100
5783
VALUATION
overvalued / fair valued / undervalued
1..100
33
Fair valued
46
Fair valued
PROFIT vs RISK RATING
1..100
76100
SMR RATING
1..100
10099
PRICE GROWTH RATING
1..100
5936
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BCRX's Valuation (33) in the Biotechnology industry is in the same range as EDIT (46). This means that BCRX’s stock grew similarly to EDIT’s over the last 12 months.

BCRX's Profit vs Risk Rating (76) in the Biotechnology industry is in the same range as EDIT (100). This means that BCRX’s stock grew similarly to EDIT’s over the last 12 months.

EDIT's SMR Rating (99) in the Biotechnology industry is in the same range as BCRX (100). This means that EDIT’s stock grew similarly to BCRX’s over the last 12 months.

EDIT's Price Growth Rating (36) in the Biotechnology industry is in the same range as BCRX (59). This means that EDIT’s stock grew similarly to BCRX’s over the last 12 months.

EDIT's P/E Growth Rating (100) in the Biotechnology industry is in the same range as BCRX (100). This means that EDIT’s stock grew similarly to BCRX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BCRXEDIT
RSI
ODDS (%)
Bullish Trend 1 day ago
71%
Bearish Trend 1 day ago
89%
Stochastic
ODDS (%)
Bullish Trend 7 days ago
85%
Bearish Trend 1 day ago
87%
Momentum
ODDS (%)
Bearish Trend 7 days ago
86%
N/A
MACD
ODDS (%)
N/A
Bullish Trend 1 day ago
78%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
80%
Bullish Trend 1 day ago
78%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
82%
Bullish Trend 1 day ago
78%
Advances
ODDS (%)
Bullish Trend 14 days ago
79%
Bullish Trend 1 day ago
77%
Declines
ODDS (%)
Bearish Trend 7 days ago
79%
Bearish Trend 8 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
88%
Aroon
ODDS (%)
Bearish Trend 1 day ago
84%
Bullish Trend 1 day ago
77%
View a ticker or compare two or three
Interact to see
Advertisement
BCRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EDIT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
EICGX17.720.08
+0.45%
Eaton Vance China Equity I
CBALX54.430.17
+0.31%
Columbia Balanced Inst
USGRX25.020.02
+0.08%
Victory Growth & Income
JDEZX14.87-0.01
-0.07%
PGIM Jennison Global Equity Income Z
SUHIX41.42-0.22
-0.53%
DWS Health and Wellness Inst

BCRX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, BCRX has been loosely correlated with VCYT. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if BCRX jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCRX
1D Price
Change %
BCRX100%
-1.05%
VCYT - BCRX
46%
Loosely correlated
-2.04%
CRNX - BCRX
41%
Loosely correlated
-0.51%
ETNB - BCRX
39%
Loosely correlated
-3.62%
BEAM - BCRX
39%
Loosely correlated
+1.35%
ROIV - BCRX
39%
Loosely correlated
+0.35%
More

EDIT and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, EDIT has been loosely correlated with CRSP. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if EDIT jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EDIT
1D Price
Change %
EDIT100%
+14.13%
CRSP - EDIT
54%
Loosely correlated
+0.31%
AXON - EDIT
52%
Loosely correlated
-0.60%
VCYT - EDIT
49%
Loosely correlated
-2.04%
NTLA - EDIT
49%
Loosely correlated
+4.73%
PRME - EDIT
48%
Loosely correlated
+10.65%
More